Empfehlungen zur kalkulierten parenteralen Initialtherapie ...

Klaus-Friedrich Bodmann, Béatrice Grabein und die Expertenkommission der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V.
Literatur
1. ARDS-Network. Ventilation with lower
tidal volumes as compared with traditional
tidal volumes for acute lung injury
and the acute respiratory distress syndrome.
N Engl J Med 2001;342:1301-8.
2. Bernard GR, Vincent JL, Laterre PF,
LaRosa S, et al. Efficacy and safety of
recombinant human activated protein
C for severe sepsis. N Engl J Med
2001;344:699-709.
3. Bone RC, Balk RA, Cerra FB, Dellinger
RP, et al. Definitions for sepsis and
organ failure and guidelines for the use
of innovative therapies in sepsis. Chest
1992;101:1644-55.
4. Briegel J. Update of the Surviving Sepsis
Campaign Guidelines 2008. Anaethesist
2008;57:284-6.
5. Brunkhorst FM, Engel C, Bloos F, Meier-
Hellmann A, et al. Intensive insulin therapy
and pentastarch resuscitation in
severe sepsis. N Engl J Med 2008;358:
125-39.
6. Cosgrowe SE, Fowler VG Jr. Management
of methicillin-resistant Staphylococcus
aureus bacteremia. Clin Infect
Dis 2008;46:S386-93.
7. Cunha BA. Sepsis and septic shock:
selection of empiric antimicrobial therapy.
Crit Care Clin 2008;24:313-34.
8. Dellinger RP, Levy M, Carlet JM, Bion J,
et al. Surviving Sepsis Campaign: international
guidelines for management of
severe sepsis and septic shock: 2008.
Intensive Care Med 2008,34:17-60.
9. Dellinger RP, Levy MM, Carlet JM, Bion
J, et al. Surviving Sepsis Campaign:
international guidelines for management
of severe sepsis and septic shock:
2008. Crit Care Med 2008;36:296-327.
10. Dellit TH, Owens RC, McGowan JE Jr,
Gerding DN, et al. Infectious Diseases
Society of America and the Society for
Healthcare Epidemiology of America
guidelines for developing an institutional
program to enhance antimicrobial
stewardship. Clin Infect Dis
2007;44:159-77.
11. Engel C, Brunkhorst FM, Bone HG,
Brunkhorst R, et al. Epidemiology of
sepsis in Germany: results from a national
prospective multicenter study. Intensive
Care Med 2007;33:606-18.
12. Fowler VG, Boucher HW, Corey GR,
Abrutyn E, et al. Daptomycin versus
standard therapy for bacteremia and
endocarditis caused by Staphylococcus
aureus. N Engl J Med 2006, 355:653-
65.
13. Garnacho-Montero J, Ortiz-Leyba C,
Herrera-Melero I, Aldabó-Pallás T, et al.
Mortality and morbidity attributable to
inadequate empirical antimicrobial therapy
in pateinst admitted to the ICU
with sepsis: a matched cohort study. J
Antimicrob Chemother 2008,61:436-
41.
70
14. Garnacho-Montero J, Sa-Borges M,
Sole-Violan J, Barcenilla F, et al. Optimal
management therapy for Pseudomonas
aeruginosa ventilator-associated pneumonia:
an observational, multicenter
study comparing monotherapy with
combination antibiotic therapy. Crit Care
Med 2007;35:1888-95.
15. Gastmeier P, Sohr D, Geffers C, Rüden
H, et al. Early and late-onset pneumonia:
is this still a useful classification?
Antimicrob Agents Chemother
2009;53:2714-8.
16. Grossi P, Gasperina DD. Antimicrobial
treatment of sepsis. Surg Infect 2006,7:
87-91.
17. Heyland DK, Dodek P, Muscedere J, Day
A, et al. Randomized trial of combination
versus monotherapy for the empiric
treatment of suspected ventilatorassociated
pneumonia. Crit Care Med
2008;36:737-44.
18. Krüger WA, Bulitta J, Kinzig-Schippers
M, et al. Evaluation by Monte Carlo
simulation of the pharmacokinetics of
two doses of meropenem administered
intermittently or as a continous infusion
in healthy volunteers. Antimicrob
Agents Chemother 2005;49:1881-9.
19. Kumar A, Ellis P, Arabi Y, Roberts D, et
al. Initiation of inappropriate antimicrobial
therapy results in a 5-fold reduction
of survival in human septic shock. Chest
2009;136:1237-48.
20. Kumar A, Roberts D, Wood KE, Light B,
et al. Duration of hypotension before
initiation of effective antimicrobial therapy
is the critical determinant of survival
in human septic shock. Crit Care
Med 2006;34:1589-96.
21. Lipman J, Boots R. A new pradigm for
beating infections: “go hard and go
home”. Crit Care Resusc 2009;11,276-
81.
22. Lorente L, Lorenzo L, Martin MM, Jiménez
A, et al. Meropenem by continous
versus intermittent infusion in ventilator-associated
pneumonia due to gramnegative
bacilli. Ann Pharmacother
2006;40:219-23.
23. Niederman MS. Use of broad-spectrum
antimicrobials for the treatment
of pneumonia in seriously ill patients:
maximizing clinical outcomes and minimizing
selection of resistant organisms.
Clin Infect Dis 2006;42:72-81.
24. Nobre V, Harbarth S, Graf JD, Rohner
P, et al. Use of procalcitonin to shorten
antibiotic treatment duration in septic
patients: a randomized trial. Am J Respir
Crit Care Med 2008;177:498-505.
25. Pappas PG, Kauffman CA, Andes D,
Benjamin DK Jr, et al. Clinical practice
guidelines for the management of candidiasis:
2009 update by the Infectious
Diseases Society of America. Clin Infect
Dis 2009;48:503-35.
26. Paul M, Benuri-Silbiger I, Soares-Weiser
K, Leibovici L. Beta-lactam monotherapy
versus beta-lactam-aminoglycoside the-
rapy for sepsis in immunocompetent
patients: systematic review and metaanalysis
of randomised trials. Br Med J
2004,328:668-72.
27. Paul M, Silbiger I, Grozinsky S, Soares-
Weiser K, et al. Beta-lactam antibiotic
monotherapy versus beta-lactam-aminoglycoside
antibiotic combination therapy
for sepsis. Cochrane Database Syst
Rev 2006:CD003344.
28. Reinhart K, Brunkhorst F, Bone H, Gerlach
H, et al. Diagnosis and therapy of
sepsis: guidelines of the German Sepsis
Society Inc. and the German Interdisciplinary
Society for Intensive and
Emergency Medicine. Anaesthesist
2006;55:43-56.
29. Rivers E, Nguyen B, Havstad S, Ressler J,
et al. Early goal-directed therapy in the
treatment of severe sepsis and septic
shock. N Engl J Med 2001;345:1368-
77.
30. Safdar N, Handelsman J, Maki DG.
Does combination antimicrobial therapy
reduce mortality in gram-negative bacteremia?
A meta-analysis. Lancet Infect
Dis 2004,4:519-27.
31. Schuster HP, Werdan K (Hrsg.). Intensivtherapie
bei Sepsis und Multiorganversa
gen. Berlin, Heidelberg: Springer,
2000.
32. Singh N, Rogers P, Atwood CW, Wagener
MM, et al. Short-course empiric
antibiotic therapy for patients with pulmonary
infiltrates in the intensive care
unit. A proposed solution for indiscriminate
antibiotic prescription. Am J Respir
Crit Care Med 2000;162:505-11.
33. Sprung CL, Annane D, Keh D, Moreno
R, et al. Hydrocortisone therapy for patients
with septic shock. N Engl J Med
2008;358:111-24.
34. Swoboda S, Hoppe-Tichy T, Geiss HK,
Hainer C, et al. Septischer Schock durch
Vancomycin-resistente Enterokokken.
Anaesthesist 2007,56:169-74.
35. Swoboda S, Ober M, Hainer C, Lichtenstern
C, et al. Tigecyclin for the treatment
of patients with severe sepsis or
septic shock: a drug use evaluation in a
surgical intensive care unit. J Antimicrob
Chemother 2008,61:729-33.
36. Torgersen C, Moser P, Luckner G, Mayr
V, et al. Macroscopic postmortem findings
in 235 surgical intensive care
patients with sepsis. Anesth Analg
2009;108:1841-7.
37. Welte T, Brunkhorst FM. Antibiotika-Therapie
der Sepsis. Med Welt
2007,58:315-21.
38. Wisplinghoff H, Bischoff T, Tallent SM,
Seifert H, et al. Nosocomial bloodstream
infections in US hospitals: analysis of
24,179 cases from a prospective nationwide
surveillance study. Clin Infect Dis
2004;39:309-17.